Food and Drug Administration
June 24, 2003
Briefing Information
Enbrel® (etanercept)
Disclaimer
The statements contained in this document(s) are those of the product's sponsor, not FDA, and FDA does not necessarily agree with the sponsor's statements. FDA has not made a final determination about the safety or effectiveness of the product described in this document.
Briefing Document Presented by Amgen, Inc. (HTM) (PDF) (Word)